Results 171 to 180 of about 14,437 (302)
Existence Results of Abstract Impulsive Integrodifferential Systems with Measure of Non-compactness [PDF]
null K. Malar, null A. Anguraj
openaire +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Leveraging foundation models to dissect the genetic basis of cluster compactness and yield in grapevine. [PDF]
Sharma S +9 more
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
The influence of city size versus urban form on land surface temperature variation and the surface urban heat island effect: A cross-city analysis of German cities. [PDF]
Doyle R +3 more
europepmc +1 more source
Descriptive Set Theory and Measure Theory in Locally Compact and Non-locally Compact Groups [PDF]
Michael P. Cohen
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
AutoXAI: a meta-learning approach for recommendation of explanation techniques. [PDF]
Shawi RE, Jamel L.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Empowering Expert Judgment: A Data-Driven Decision Framework for Standard Setting in High-Dimensional and Data-Scarce Assessments. [PDF]
Zheng T, Jiang Z, Guo Z, Liu Y.
europepmc +1 more source

